Dr. Pravin Chaturvedi is the Chairman of the Scientific Advisory Board for Napo Pharmaceuticals and is the CEO for IndUS and Oceanyx Pharmaceuticals. He is an experienced drug developer and biotech entrepreneur. Previously he was the CEO of Pivot and Scion Pharmaceuticals; and was the Head of Lead Evaluation at Vertex and was in Product Development groups at Alkermes and Parke-Davis/Warner-Lambert (Pfizer). Over his career, he has participated in the successful development of several new drugs for the treatment of CNS, viral and gastrointestinal disorders. Dr. Chaturvedi serves on the boards of Oceanyx, IndUS, Cellanyx, FuelEd Schools and Sindu Research Laboratories; and previously served on the boards of Pivot, Scion, Bach Pharma, PRADAN USA, Sindu Pharmaceuticals and TiE Boston. He is an adjunct faculty member at Georgetown Medical School and serves on several advisory boards. He holds a Ph.D. in Pharmaceutical Sciences from West Virginia University.
